Imperative Care has completed subject enrolment in the pivotal IDE trial, SYMPHONY-PE, to treat acute pulmonary embolism.

Imperative Care announced today that it completed enrollment in the SYMPHONY-PE pivotal investigational device exemption (IDE ...

Issues delivered straight to your door or device If you can call $899 affordable, I guess.

Lipogems is proud to announce the completion of the ARISE I U.S. FDA IDE Study with the last patient's last visit successfully completed. This milestone marks the conclusion of a key phase in the ...

JetBrains Junie, the AI assistant IDE that learns your coding style and simplifies workflows. Offering adaptive coding & ...